Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | KDM1B | Q8NB78 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15421678 | 0.79 | — | — | |
| SCHEMBL7523758 | 0.79 | CES2 (0.31) | — | |
| SCHEMBL13488 | 0.77 | CES2 (0.36) | — | |
| SCHEMBL29888885 | 0.75 | KDM1A (0.35) | KDM1AKCNH2KDM1B | |
| SCHEMBL20870374 | 0.75 | KDM1A (0.35) | KDM1AKCNH2KDM1B | |
| SCHEMBL22289556 | 0.75 | KDM1A (0.31) | KDM1AKCNH2KDM1B | |
| SCHEMBL31489883 | 0.75 | KDM1A (0.31) | KDM1AKCNH2KDM1B | |
| SCHEMBL22289306 | 0.75 | NPC1 (0.32) | — | |
| SCHEMBL8049727 | 0.75 | KDM1A (0.32) | KDM1AKCNH2KDM1B | |
| SCHEMBL577838 | 0.75 | KDM1A (0.41) | KDM1AKCNH2KDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739682-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| US-12497389-B2 | Organic electroluminescence device and heterocyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-12-16 | — | — | US | disclosed |
| EP-4029864-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025008058-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | JANSSEN PHARMACEUTICA NV (BE) | 2025-01-09 | — | — | WO | disclosed |
| CN-119143738-A | Organic electroluminescent device and heterocyclic compound for organic electroluminescent device | 三星显示有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-110642847-B | Organic electroluminescent device and heterocyclic compound for organic electroluminescent device | 三星显示有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-20240251671-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-25 | — | — | US | disclosed |
| US-11968891-B2 | Organic electroluminescence device and heterocyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-04-23 | — | — | US | disclosed |
| US-20220396568-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-12-15 | — | — | US | disclosed |
| EP-4056566-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT Materials Co., Ltd. (KR) | 2022-09-14 | — | — | EP | disclosed |
| EP-4029864-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | Samsung Display Co., Ltd. (KR) | 2022-07-20 | — | — | EP | disclosed |
| CN-114341130-A | Heterocyclic compound, organic light-emitting element comprising same, composition of organic material layer for organic light-emitting element, and method for manufacturing organic light-emitting element | LT素材株式会社 | 2022-04-12 | — | — | CN | disclosed |
| EP-3587415-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2022-03-16 | — | — | EP | disclosed |
| EP-3860994-A1 | TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | The University of British Columbia (CA) | 2021-08-11 | — | — | EP | disclosed |
| WO-2020069625-A1 | TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-04-09 | — | — | WO | disclosed |
| CN-110642847-A | Organic electroluminescent device and heterocyclic compound for organic electroluminescent device | 三星显示有限公司 | 2020-01-03 | — | — | CN | disclosed |
| US-9556143-B2 | Metalloenzyme inhibitor compounds | VIAMET PHARMACEUTICALS, INC. (US) | 2017-01-31 | — | — | US | disclosed |
| US-20160214959-A1 | METALLOENZYME INHIBITOR COMPOUNDS | NQP 1598, LTD. (KY) | 2016-07-28 | — | — | US | disclosed |
| US-20150099750-A1 | METALLOENZYME INHIBITOR COMPOUNDS | Viamet Pharmaceuticals (NC), Inc. | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396568-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP1B1, CRY1 | KDM1A 666/4885KCNH2 2100/4885KDM1B 1440/4885 |
| US-20240251671-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | OCIAD1, OCIAD2, SLC25A21 | KDM1A 2259/4885KCNH2 149/4885KDM1B 2561/4885 |
| US-20150099750-A1 | METALLOENZYME INHIBITOR COMPOUNDS | MMEL1, GPX1, MPO | KDM1A 2556/4885KCNH2 2250/4885KDM1B 2819/4885 |
| US-12497389-B2 | Organic electroluminescence device and heterocyclic compound for organic electroluminescence device | OCIAD1, OCIAD2, SLC25A21 | KDM1A 2259/4885KCNH2 149/4885KDM1B 2561/4885 |
| US-11968891-B2 | Organic electroluminescence device and heterocyclic compound for organic electroluminescence device | OCIAD1, OCIAD2, SLC25A21 | KDM1A 2259/4885KCNH2 149/4885KDM1B 2561/4885 |
| US-20160214959-A1 | METALLOENZYME INHIBITOR COMPOUNDS | MMEL1, GPX1, MPO | KDM1A 2556/4885KCNH2 2250/4885KDM1B 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.